title: Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.
authors.affiliation: University Medical Center Duesseldorf, Institue of Hemostasis and Transfusion Medicine, Moorenstr. 5, 40225 Duesseldorf, Germany. marcus.stockschlaeder@uni-duesseldorf.de
authors.forename: Marcus
authors.initials: M
authors.lastname: Stockschläder
authors.forename: Leilani
authors.initials: L
authors.lastname: Ruf
authors.forename: Anne
authors.initials: A
authors.lastname: Linderer
authors.forename: Thomas
authors.initials: T
authors.lastname: Schroeder
authors.forename: Wolfram T
authors.initials: WT
authors.lastname: Knoefel
authors.forename: Rainer
authors.initials: R
authors.lastname: Haas
authors.forename: Günther
authors.initials: G
authors.lastname: Giers
authors.forename: Andrea
authors.initials: A
authors.lastname: Gerhardt
authors.forename: Christoph
authors.initials: C
authors.lastname: Sucker
authors.forename: Rainer B
authors.initials: RB
authors.lastname: Zotz
authors.forename: Rüdiger E
authors.initials: RE
authors.lastname: Scharf
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000628:therapy; D006470:Hemorrhage / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D000069283:Rituximab
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001779:Blood Coagulation Factors; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D000069283:Rituximab; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa